Capozide 50/25 and Moxetumomab pasudotox
Determining the interaction of Capozide 50/25 and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: captopril / hydrochlorothiazide
Brand name: Capozide 25/15, Capozide 25/25, Capozide 50/15, Capozide 50/25
Synonyms: Capozide 50/25 (Oral)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Capozide 50/25-Moxetumomab Pasudotox-tdfk
- Capozide 50/25-Moxetumomab pasudotox-tdfk Intravenous
- Capozide 50/25-Moxifloxacin
- Capozide 50/25-Moxifloxacin (Systemic)
- Capozide 50/25-Moxifloxacin Hydrochloride
- Capozide 50/25-Moxifloxacin Injection
- Moxetumomab pasudotox-Caprelsa
- Moxetumomab pasudotox-Capreomycin
- Moxetumomab pasudotox-Capreomycin Injection
- Moxetumomab pasudotox-Capreomycin Sulfate
- Moxetumomab pasudotox-Capron DM
- Moxetumomab pasudotox-Capsagel